US EditionTop US Court to Hear Challenge to Purdue Pharma's $6 Billion Opioid Settlement
- The Supreme Court is hearing oral arguments regarding the approval of a controversial agreement by OxyContin-maker Purdue Pharma, which would provide billions of dollars to victims of the opioid epidemic while protecting the Sackler family from lawsuits.
- The deal involves the Sackler family paying between $5.5 billion to $6 billion to help fight the opioid crisis, with the majority going to states, local governments, and Native American tribes.
- If approved, the settlement would shield the Sackler family from future lawsuits and create a new company, Knoa Pharma, to distribute opioid addiction treatments and overdose reversal medicines.
155 Articles
155 Articles
The Supreme Court wrestles with OxyContin maker’s bankruptcy deal, with billions of dollars at stake - West Hawaii Today
WASHINGTON — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.
The Supreme Court wrestles with OxyContin maker’s bankruptcy deal, with billions of dollars at stake
WASHINGTON — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.
The Supreme Court wrestles with OxyContin maker’s bankruptcy deal, with billions of dollars at stake
WASHINGTON — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids. The justices seemed by turns reluctant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers. The agreement hammered out with state and local governments and victims would prov…
Supreme Court wrestles with OxyContin maker’s bankruptcy deal, with billions of dollars at stake
The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.
Supreme Court wrestles with OxyContin maker’s bankruptcy deal
WASHINGTON >> The Supreme Court today wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.
Coverage Details
Bias Distribution
- 62% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
